FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1045377105> ?p ?o ?g. }

• W1045377105 endingPage "26" @default.
• W1045377105 startingPage "107" @default.
• W1045377105 abstract "Prostaglandins (PG), the products of arachidonate metabolism through cyclooxygenase (COX) pathway, protect the pancreas from the acute damage. The existence of two isoforms of COX was documented including: COX-1, present in normal tissues and COX-2, expressed at the site of inflammation, such as induced by bacterial lipopolysaccharide (LPS). Pretreatment with low dose of LPS and activation of nitric oxide (NO) synthase (NOS) has been shown to prevent the injury caused by caerulein-induced pancreatitis (CIP) in the rat. The aim of this study was to investigate the role of COX-1 and COX-2 in the LPS-induced protection of the pancreas against CIP and the involvement of NOS in the activation of COX-PG system in the rats with CIP. CIP was produced by subcutaneous (s.c.) infusion of caerulein (5 microg/kg-h for 5 h) to the conscious rats. Protective dose of LPS, from Escherichia coli, (1 mg/kg) was given intraperitoneally (i.p.) 15 min prior to the start of CIP. Nonselective inhibitor of COX; indomethacin (5 or 10 mg/kg), selective inhibitor of COX-1: resveratrol, or a highly selective inhibitors of COX-2: rofecoxib or NS-398 (2 or 10 mg/kg) were injected i.p. 15 min prior to the administration of LPS. COX-1 or COX-2 mRNA was determined by reverse transcription-polimerase chain reaction (RT-PCR) in the pancreatic tissue. Pancreatic blood flow (PBF) was measured by a laser Doppler flowmetry. PGE2 content in the pancreas was measured by radioimmunoassay. CIP was manifested by an increase of pancreatic weight and plasma amylase activity (by 500% and 700%, respectively) and it was confirmed by histological examination. CIP slightly increased pancreatic PGE2 generation (by 12%) and diminished PBF (by about 40%). LPS (1 mg/kg i.p.), given prior to the start of CIP, increased PGE2 generation in the pancreas (by 45%), reversed the histological manifestations of pancreatitis, reduced the rise in amylase blood level and improved PBF. Administration of nonselective inhibitor of COX; indomethacin (5 or 10 mg/kg i.p.) prior to the injection of LPS abolished its protective effects on CIP and reduced pancreatic PGE2 generation. Selective inhibitor of COX-1; resveratrol (10 mg/kg i.p.) given prior to the injection of LPS reversed its protective effects against CIP. Pretreatment with a selective inhibitors of COX-2: rofecoxib or NS-398 (10 mg/kg) attenuated LPS-induced pancreatic protection in the CIP rats. COX-1 expression was detected in the intact pancreas and was not significantly changed by CIP, LPS, indomethacin, NS-389 and their combination, while COX-2 mRNA expression appeared in the pancreas of ratssubjected to CIP and was significantly increased after LPS injection to these rats. Addition of selective COX-2 inhibitor; NS-389, or nonselective inhibitor of COX; indomethacin, enhanced COX-2 mRNA expression in the rats with CIP pretreated with LPS. Pretreatment of the rats with inhibitor of NOS; L-NNA (20 mg/kg i.p.), given together with LPS, 15 min prior to the start of caerulein overstimulation, resulted in complete reversion of LPS-induced pancreatic protection and decreased PGE2 generation stimulated by LPS. Addition to L-NNA of the substrate for NOS; L-arginine (100 mg/kg i.p.), restored pancreatic protection afforded by low dose of LPS and increased pancreatic PGE2 level in the rats with CIP. We conclude that: 1. increased pancreatic PGE2 generation, induced by low dose LPS pretreatment, contributes to the pancreatic resistance to acute damage produced by caerulein overstimulation and 2. the NO-system is involved in above stimulation of PGE2 generation and pancreatic protection against acute damage." @default.
• W1045377105 created "2016-06-24" @default.
• W1045377105 creator A5003372896 @default.
• W1045377105 creator A5007190223 @default.
• W1045377105 creator A5015501774 @default.
• W1045377105 creator A5028649097 @default.
• W1045377105 creator A5062048908 @default.
• W1045377105 creator A5063091785 @default.
• W1045377105 creator A5068128072 @default.
• W1045377105 creator A5068449711 @default.
• W1045377105 creator A5087690868 @default.
• W1045377105 creator A5088799288 @default.
• W1045377105 creator A5091650546 @default.
• W1045377105 date "2001-03-01" @default.
• W1045377105 modified "2023-10-18" @default.
• W1045377105 title "Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide." @default.
• W1045377105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11321505" @default.
• W1045377105 hasPublicationYear "2001" @default.
• W1045377105 type Work @default.
• W1045377105 sameAs 1045377105 @default.
• W1045377105 citedByCount "13" @default.
• W1045377105 countsByYear W10453771052014 @default.
• W1045377105 countsByYear W10453771052015 @default.
• W1045377105 countsByYear W10453771052017 @default.
• W1045377105 countsByYear W10453771052018 @default.
• W1045377105 crossrefType "journal-article" @default.
• W1045377105 hasAuthorship W1045377105A5003372896 @default.
• W1045377105 hasAuthorship W1045377105A5007190223 @default.
• W1045377105 hasAuthorship W1045377105A5015501774 @default.
• W1045377105 hasAuthorship W1045377105A5028649097 @default.
• W1045377105 hasAuthorship W1045377105A5062048908 @default.
• W1045377105 hasAuthorship W1045377105A5063091785 @default.
• W1045377105 hasAuthorship W1045377105A5068128072 @default.
• W1045377105 hasAuthorship W1045377105A5068449711 @default.
• W1045377105 hasAuthorship W1045377105A5087690868 @default.
• W1045377105 hasAuthorship W1045377105A5088799288 @default.
• W1045377105 hasAuthorship W1045377105A5091650546 @default.
• W1045377105 hasConcept C126322002 @default.
• W1045377105 hasConcept C134018914 @default.
• W1045377105 hasConcept C176685330 @default.
• W1045377105 hasConcept C181199279 @default.
• W1045377105 hasConcept C185592680 @default.
• W1045377105 hasConcept C2777622882 @default.
• W1045377105 hasConcept C2777956040 @default.
• W1045377105 hasConcept C2778754761 @default.
• W1045377105 hasConcept C2778764654 @default.
• W1045377105 hasConcept C2779689624 @default.
• W1045377105 hasConcept C2780664492 @default.
• W1045377105 hasConcept C519581460 @default.
• W1045377105 hasConcept C55493867 @default.
• W1045377105 hasConcept C71924100 @default.
• W1045377105 hasConcept C98274493 @default.
• W1045377105 hasConceptScore W1045377105C126322002 @default.
• W1045377105 hasConceptScore W1045377105C134018914 @default.
• W1045377105 hasConceptScore W1045377105C176685330 @default.
• W1045377105 hasConceptScore W1045377105C181199279 @default.
• W1045377105 hasConceptScore W1045377105C185592680 @default.
• W1045377105 hasConceptScore W1045377105C2777622882 @default.
• W1045377105 hasConceptScore W1045377105C2777956040 @default.
• W1045377105 hasConceptScore W1045377105C2778754761 @default.
• W1045377105 hasConceptScore W1045377105C2778764654 @default.
• W1045377105 hasConceptScore W1045377105C2779689624 @default.
• W1045377105 hasConceptScore W1045377105C2780664492 @default.
• W1045377105 hasConceptScore W1045377105C519581460 @default.
• W1045377105 hasConceptScore W1045377105C55493867 @default.
• W1045377105 hasConceptScore W1045377105C71924100 @default.
• W1045377105 hasConceptScore W1045377105C98274493 @default.
• W1045377105 hasIssue "1" @default.
• W1045377105 hasLocation W10453771051 @default.
• W1045377105 hasOpenAccess W1045377105 @default.
• W1045377105 hasPrimaryLocation W10453771051 @default.
• W1045377105 hasRelatedWork W1517598754 @default.
• W1045377105 hasRelatedWork W1939319907 @default.
• W1045377105 hasRelatedWork W1971822195 @default.
• W1045377105 hasRelatedWork W1990567068 @default.
• W1045377105 hasRelatedWork W2040262314 @default.
• W1045377105 hasRelatedWork W2086232570 @default.
• W1045377105 hasRelatedWork W2091494117 @default.
• W1045377105 hasRelatedWork W2098857326 @default.
• W1045377105 hasRelatedWork W2496690816 @default.
• W1045377105 hasRelatedWork W2978537570 @default.
• W1045377105 hasVolume "52" @default.
• W1045377105 isParatext "false" @default.
• W1045377105 isRetracted "false" @default.
• W1045377105 magId "1045377105" @default.
• W1045377105 workType "article" @default.